Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib combined TACE in advanced hepatocellular carcinoma
ChiCTR-OPN-16009457Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 1990
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of latanoprost in hepatocellular carcinoma (HCC), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Progression-free survival. Started Jan 1990; status: recruiting.
02
Drugs
latanoprost
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on ChiCTR-OPN-16009457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-16009457.